Purpose: Posterior capsule opacification (PCO) after cataract surgery is due in part to proliferation of the adhering lens epithelial cells and transdifferentiation into mesenchymal cells. The histone deacetylase (HDAC) inhibitors, trichostatin A (TSA) and vorinostat (suberoylanilidehydroxamic acid [SAHA]) are known to modulate cell proliferation and epithelial-mesenchymal transition (EMT). Studies have shown that TGFβ2 can induce EMT similar to that seen during PCO. This study evaluated the effects of TSA and SAHA on TGFβ2-induced EMT in lens epithelial explants.

Methods: Epithelial cells adherent to lens capsules were isolated from fresh pig lenses and human donor lenses and cultured for 12 hours. Explants were pretreated with TSA or SAHA for 1 hour and then treated with TGFβ2 for up to 3 days. Scratch wound healing assay was used to determine epithelial cell proliferation and migration in the samples. The effects of TSA and SAHA on histone acetylation and HDAC 1 to 6 levels were analyzed by Western blotting.

Results: Western blotting and immunocytochemistry demonstrated high expression of α-SMA in lens epithelial cells treated with TGFβ2. The HDAC inhibitors exerted dose-dependent inhibition of α-SMA expression, with complete inhibition occurring with 0.5 μM of TSA and 2.5 μM of SAHA. Transforming growth factor β2-induced EMT was suppressed by TSA and SAHA. Histone deacetylase inhibition in pig lens epithelia led to increased acetylation of histone 3 and 4 at multiple sites.

Conclusions: Histone deacetylase inhibitors, TSA, and SAHA prevent EMT in lens epithelial explants. The results also suggest that the epigenetic modifiers are the potential targets to control PCO after cataract surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.14-14109DOI Listing

Publication Analysis

Top Keywords

tsa saha
20
histone deacetylase
16
lens epithelial
16
epithelial cells
12
deacetylase inhibitors
8
inhibitors trichostatin
8
pco cataract
8
cataract surgery
8
hdac inhibitors
8
cell proliferation
8

Similar Publications

Distribution and diversity of classical deacylases in bacteria.

Nat Commun

November 2024

Department Synthetic and Structural Biochemistry, Institute of Biochemistry, University of Greifswald, Greifswald, Germany.

Classical Zn-dependent deac(et)ylases play fundamental regulatory roles in life and are well characterized in eukaryotes regarding their structures, substrates and physiological roles. In bacteria, however, classical deacylases are less well understood. We construct a Generalized Profile (GP) and identify thousands of uncharacterized classical deacylases in bacteria, which are grouped into five clusters.

View Article and Find Full Text PDF

Castration-resistant prostate cancer (CRPC) contributes mostly to prostate cancer-specific mortality, and conventional castration therapy is almost ineffective, new therapies are needed. As a new potential anti-cancer drug, histone deacetylases (HDACs) inhibitors were demonstrated to be effective in inhibiting drug-resistance cancers in preclinical studies, but the results from clinical trials on CRPC patients were disappointing, and the reasons are unknown. In this study, we investigated the effect of suberanilohydroxamic acid (SAHA), a broad-spectrum pan-HDAC inhibitor, on proliferation, apoptosis, cell cycle progression in PC3 cells, and found that, unlike significant inhibiting effects at high-dose, low-dose SAHA significantly promoted PC3 cell growth.

View Article and Find Full Text PDF
Article Synopsis
  • The research focuses on creating new drug alternatives using cashew nutshell liquid (CNSL) as a source, aiming for environmentally friendly and health-focused solutions.
  • A method called metathesis was used to synthesize these compounds, which were found to be non-toxic to several cell lines.
  • One of the compounds showed significant effectiveness against certain parasitic diseases, with its mechanism of action linked to the inhibition of a specific enzyme (HDAC) in parasites.
View Article and Find Full Text PDF
Article Synopsis
  • A differential diet with royal jelly during honeybee larval development affects their phenotype, likely through epigenetic changes in gene expression.
  • Research shows that royal jelly contains compounds, like 10-hydroxy-2-decenoic acid (10-HDA), that can inhibit enzymes known as histone deacetylases (HDACs), which are important for regulating gene activity.
  • Experimental and computational analyses suggest that fatty acids from royal jelly, especially 10-HDA and 10-HDAA, may serve as weak HDAC inhibitors, promoting increased gene expression in human cancer cells.
View Article and Find Full Text PDF

Unlabelled: Chemotherapy is one of the most well-established and effective cancer treatments available. However, non-tumor-associated damage restrict the treatment's effectiveness and safety. Our growing understanding of cancer epigenetics has resulted in new therapeutic options and the potential of better patient outcomes in recent decades.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!